Document and Entity Information |
Mar. 09, 2022 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Mar. 09, 2022 |
| Entity Registrant Name | Poseida Therapeutics, Inc. |
| Entity Central Index Key | 0001661460 |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity File Number | 001-39376 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 47-2846548 |
| Entity Address, Address Line One | 9390 Towne Centre Drive |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92121 |
| City Area Code | 858 |
| Local Phone Number | 779-3100 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, par value $0.0001 per share |
| Trading Symbol | PSTX |
| Security Exchange Name | NASDAQ |